Prevalences of Gsα, ras, p53 mutations and ret/PTC rearrangement in differentiated thyroid tumours in a Korean population

Clinical Endocrinology

Volumn 49, Issue 3, 1998, Pages 317-323

  Park, K Y ^b   Koh, J M ^a   Kim, Y I ^a   Park, H J ^b   Gong, G ^a   Hong, S J ^a   Ahn, I M ^a,c  

^a University of Ulsan College of Medicine   (South Korea)

^b Asan Institute for Life Sciences   (South Korea)

^c Asan Medical Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; ONCOPROTEIN; PROTEIN BCL 2; PROTEIN P53; RAS PROTEIN;

ARTICLE; CONTROLLED STUDY; GENE MUTATION; GENE REARRANGEMENT; GOITER; HUMAN; HUMAN TISSUE; KOREA; MAJOR CLINICAL STUDY; ONCOGENE; PRIORITY JOURNAL; THYROID ADENOMA; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROID TUMOR; TUMOR DIFFERENTIATION; TUMOR SUPPRESSOR GENE;

ADENOMA; CARCINOMA; CARCINOMA, PAPILLARY; CARCINOMA, PAPILLARY, FOLLICULAR; DROSOPHILA PROTEINS; GENE REARRANGEMENT; GENES, P53; GENES, RAS; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HUMANS; IMMUNOHISTOCHEMISTRY; KOREA; NEOPLASM PROTEINS; NUCLEAR PROTEINS; ONCOGENE PROTEINS; POINT MUTATION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PREVALENCE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-MDM2; PROTO-ONCOGENE PROTEINS C-RET; RECEPTOR PROTEIN-TYROSINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THYROID NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031783481     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1998.00515.x     Document Type: Article

References (34)

1. Basolo, F., Pollina, L., Fontanini, F., Fiore, L., Pacini, F. & Baldanzi, A. (1997) Apoptosis and proliferation in thyroid carcinoma: correlation with bcl-2 and p53 protein expression. British Journal of Cancer, 75, 537-541.
2. Becker, D.V., Robbins, J., Beebe, G.W., Bouville, A.C. & Wachholz, B.W. (1996) Childhood thyroid cancer following Cherobyl accident: a status report. Endocrinology and Metabolism Clinics of North America, 25, 197-211.
3. Burman, K.D., Ringel, M.D. & Wartofsky, L. (1996) Unusual types of thyroid neoplasms. Endocrinology and Metabolism Clinics of North America, 26, 49-68.
4. DeGroot, L.J., Kaplan, E.L., McCormick, M. & Straus, F.H. (1990) Natural history, treatment, and course of papillary thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism, 71, 414-424.
5. Dobashi, Y., Sakamoto, A., Sugimura, H., Mernua, M., Mori, M., Oyama, T. & Machinami, R. (1993) Overexpression of p53 as a possible prognostic factor in human thyroid carcinoma. American Journal of Surgical Pathology, 17, 375-381.
6. Fagin, J.M. (1992) Genetic basis of endocrine disease 3: molecular defects in thyroid gland neoplasia. Journal of Clinical Endocrinology and Metabolism, 75, 1398-1400.
7. Farid, N.R., Shi, Y. & Zou, M. (1994) Molecular basis of thyroid cancer. Endocrine Review, 15, 202-232.
8. Farid, N.R., Zou, M. & Shi, Y. (1995) Genetics of follicular thyroid cancer. Endocrinology and Metabolism Clinics of North America, 24, 865-883.
9. Friend, S. (1994) A glimpse at the puppet behind the shadow play. Science, 265, 334-335.
10. Fugazzola, L., Pierotti, M.A., Vigano, E., Pacini, F., Vorontsova, T.V. & Bongarzone, I. (1996) Molecular and biochemical analysis of RET/PTC4, a novel oncogenic rearrangement between RET and ELE1 genes, in a post-Chernobyl papillary thyroid cancer. Oncogene, 13, 1093-1097.
11. Gersimov, G., Bronstein, M., Troshina, K., Alexandrov, G., Deirov, I., Lesisos, T., Kalikarury, B.V., Izaquterdo, R., Bogunewicz, A., Robbison, L., Breese, K., Ross, J.S. & Figge, J. (1995) Nuclear p53 immunoreactivity in papillary thyroid cancers is associated with two established indicators of poor prognosis. Experimental and Molecular Pathology, 62, 52-62.
12. Gorelov, V.N., Gyense, M., Neser, F., Roher, H.D. & Goretzki, P.E. (1996) Distribution of Gs-alpha activating mutations in human thyroid tumors measured by subcloning. Journal of Cancer Research and Clinical Oncology, 122, 453-457.
13. Holm, R. & Nesiland, J.M. (1994) Retinoblastoma and p53 tumor suppressor gene protein expression in carcinomas of the thyroid gland. Journal of Pathology, 172, 267-272.
14. Hosai, S.A., Apel, R.L., Freeman, J.L., Azadian, A., Rosen, I.B., Livolsi, V.A. & Asa, S.L. (1997) Immunohistochemical localization of P53 in human thyroid neoplasms - Correlation with biological behavior. Endocrine Pathology, 8, 21-28.
15. Hsu, S.M., Raine, L. & Fanger, H. (1981) The use of avidin-biotin peroxidase complex (ABC) in immunoperoxidase techniques; a comparison between ABC and unlabeled antibody (PAP) procedures. American Journal of Clinical Pathology, 29, 577-581.
16. Ito, T., Seyama, T., Mizuno, T., Tsuyama, N., Hayashi, T., Hayashi, Y., Dohi, K., Nakamura, N. & Akiyama, M. (1992) Unique association of p53 mutations with undifferentiated hut not with differentiated carcinomas of the thyroid gland. Cancer Research, 52, 1369-1371.
17. Jennings, T., Bratsavsky, G., Gersimov, G., Troshina, K., Bronstein, M., Dedov, I., Alexandrova, G. & Figge, J. (1995) Nuclear accumulation of MDM2 protein in well-differentiated papillary thyroid carcinomas. Experimental and Molecular Pathology, 62, 199-206.
18. Kaufman, P.B., Wu, W., Kim, D. & Cseke, L. (1995) Isolation and purification of DNA. In Handbook of Molecular and Cellular Methods in Biology and Medicine (eds P.B. Kaufman, W. Wu, D. Kim & L. Cseke), pp. 1-26. CRC Press, Boca Raton.
19. Klugbauer, S., Lengfelder, E., Deemidchik, E.P. & Rabes, H.H. (1995) High prevalence of RET rearrangement in thyroid tumors of children from Belarus after the Chernobyl reactor accident. Oncogene, 11, 2459-2467.
20. Kramer, J.B. & Wells, Jr S.A. (1989) Thyroid carcinoma. Advances in Surgery, 32, 195-224.
21. Orita, M., Suzuki, Y., Seikiya, T. & Hayashi, K. (1989) Rapid and sensitive detection of point mutations and DNA polymorphisms using polymerase chain reaction. Genomics, 5, 874-879.
22. Pollina, L., Pacini, F., Fontanini, G., Vignati, S., Bevilacqua, G. & Basolo, F. (1996) bcl-2, p53 and proliferating cell nuclear antigen expression is related to the degree of defferentiation in thyroid carcinomas. British Journal of Cancer, 73, 139-143.
23. Prives, C. (1994) How loops, beta sheets, and alpha helices help us to understand p53. Cell, 78, 543-546.
24. Said, S., Schlumberger, M. & Suarez, H.G. (1994) Oncogenes and anti-oncogenes in human epithelial thyroid tumors. Journal of Endocrinological Investigation, 17, 371-379.
25. Shi, Y.F., Zou, M.J., Schimidt, H., Juhasz, F., Stenszky, V., Robb, D. & Farid, N.R. (1991) High rates of ras codon 61 mutation in thyroid tumors in an iodide-deficient area. Cancer Research, 51, 2690-2693.
26. Song, M.H. & Chang, S.K. (1993) Mutations of K-ras oncogene in thyroid tumor tissue [in Korean]. Journal of the Catholic Medical College, 46, 139-147.
27. Spambalg, D., Sharifi, N., Elisei, R., Gross, J.L., Medeiros-Neto, G. & Fagin, J.A. (1996) Structural studies of the thyrotropin receptor and Gs α in human thyroid cancers: low prevalence of mutations predicts infrequent involvement in malignant transformations. Journal of Clinical Endocrinology and Metabolism, 81, 3898-3901.
28. Sugg, S.L., Zheng, L., Rosen, I.B., Freeman, J.L., Ezzat, S. & Asa, S. (1996) ret/PTC-1, -2, and -3 oncogene rearrangements in human thyroid carcinomas: implications for metastatic potential? Journal of Clinical Endocrinology and Metabolism, 81, 3360-3365.
29. Takeshita, A., Nagayama, Y., Yokoyama, N., Ishikawa, N., Ito, K., Yamashita, T., Obera, T., Murakan, Y., Kuma, K. & Takamatsu, J. (1995) Rarity of oncogenic mutations in the thyrotropin receptor of autonomously functioning thyroid nodules in Japan. Journal of Clinical Endocrinology and Metabolism, 80, 2607-2611.
30. Tanaka, K., Nagayama, Y., Takeshita, A., Namba, H., Yamashita, S., Niwa, M. & Nagataki, S. (1996) Low incidence of the stimulatory G protein α-subunit mutation in autonomously functioning thyroid adenomas in Japan. Thyroid, 6, 195-199.
31. Viglietto, G., Chiapetta, G., Martinez-Tello, F.J., Fuknaga, F.H., Tallini, G., Rigopoulou, D., Visconti, R., Mastro, A., Santoro, M. & Fusco, A. (1995) RET/PTC oncogene activation is an early event in thyroid carcinogenesis. Oncogene, 11, 1207-1210.
32. Yoshimoto, K., Iwahana, H., Fukuda, A., Sano, T. & Itakura, M. (1993) Rare mutations of Gs alpha subunit gene in human endocrine tumors. Mutation detection by polymerase chain reaction-prime introduced restriction analysis. Cancer, 72, 1386-1393.
33. Zou, M., Shi, Y. & Farid, N.R. (1993) p53 Mutations in all stages of thyroid carcinomas. Journal of Clinical Endocrinology and Metabolism, 77, 1054-1058.
34. Zou, M., Shi, Y., Al-Sedairy, S., Hussain, S.S. & Farid, N.R. (1995) The expression of the MDM2 gene, a p53 bidning protein, in thyroid carcinogenesis. Cancer, 76, 314-318.